L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
fA0zRvafcmDN9aC7